Bibliography
- Leroy O , GangneuxJP, MontraversPet al.: Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006).Crit. Care Med.37(5) , 1612–1618 (2009).
- Poikonen E , LyytikäinenO, RuutuP: Candidemia in Finland, 1995–1999 versus 2004–2007. Presented at: 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Helsinki, Finland, 16–19 May 2009.
- Das I , JumaaP, NightingaleP, PatelM: The pattern of candidemia in a tertiary referral hospital in the United Kingdom. Presented at: 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Helsinki, Finland, 16–19 May 2009.
- Playford EG , NimmoGR, TilseM, SorrellTC: The increasing incidence of candidemia and the increasing importance of non-ICU/non-haematology patients: secular trends, Queensland, Australia, 1999–2008. Presented at: 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Helsinki, Finland, 16–19 May 2009.
- Lortholary O , GangneuxJP, SitbonKet al.: Prospective surveillance of invasive aspergillosis in 4 French regions: 2005–2007. Presented at: 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Helsinki, Finland, 16–19 May 2009.
- Rüping M , VehreschildJJ, BeiselCet al.: Fungiscope: a global database for rare fungal infections. Presented at: 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Helsinki, Finland, 16–19 May 2009.
- Lass-Flörl C , EschertzhuberS, AubergerJ, GeltnerC, NachbaurD: Airborne fungus – exposure prior to hospitalization as risk factor for mould infections in immunocompromised patients. Presented at: 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Helsinki, Finland, 16–19 May 2009.
- Hui M , HoWH, LamWH: Candida glabrata fungaemia: the importance of anaerobic blood culture.J. Med. Microbiol.58(Pt 3) , 396–397 (2009).
- Husain S , PatersonDL, StuderSMet al.: Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients.Transplantation83(10) , 1330–1336 (2007).
- Meersseman W , LagrouK, MaertensJet al.: Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.Am. J. Respir. Crit. Care Med.177(1) , 27–34 (2008).
- Maertens J , BuvéK, TheunissenKet al.: Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients.Cancer115(2) , 355–362 (2009).
- Cordonnier C , PautasC, MaurySet al.: Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.Clin. Infect. Dis.48(8) , 1042–1051 (2009).
- Presterl E , ParschalkB, BauerE, LassniggA, HajduS, GraningerW: Invasive fungal infections and (1,3)-β-D-glucan serum concentrations in long-term intensive care patients.Int. J. Infect. Dis. (2009) (Epub ahead of print).
- Walsh TJ , AnaissieEJ, DenningDWet al.: Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.Clin. Infect. Dis.46 , 327–360 (2008).
- Pappas PG , KauffmanCA, AndesDet al.: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.Clin. Infect. Dis.48(5) , 503–535 (2009).
- Guidelines from the First European Conference on Infections in Leukemia: ECIL 1. Guest editors: Cordonnier C, Calandra T, Meunier F. Eur. J. Cancer5(Suppl.) , 1–59 (2007).
- Holzknecht BJ , KnudsenJD: Decreasing candidemia rate in abdominal surgery patients after introduction of prophylactic and early presumptive therapy with fluconazole. Presented at: 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Helsinki, Finland, 16–19 May 2009.
- Alvarez-Lerma F , DíazJ, MariscalF, NietoM, Austin I; on behalf of the study group for Liposomal Amphotericin B: Efficacy and safety of liposomal amphotericin B in intensive care unit patients with confirmed invasive fungal infection: a retrospective, multi-centre study. Presented at: 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Helsinki, Finland, 16–19 May 2009.
- Álvarez-Lerma F , RialpG, NietoM, AragonT, PueneteT, Ausin I; on behalf of the study group for Liposomal Amphotericin B: Liposomal amphotericin B in intensive care unit patients previously treated with fluconazole: a retrospective, efficacy and safety multi-centre study. Presented at: 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Helsinki, Finland, 16–19 May 2009.
- Cornely OA , MaertensJ, WinstonDJet al.: Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.N. Engl. J. Med.356(4) , 348–359 (2007).
- Hope W : PK/PD and azoles. Presented at: 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Helsinki, Finland, 16–19 May 2009.